Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion type Assertion NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_head.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion description "[The objective of this study was to use a potent new-generation MEK inhibitor PD0325901 to further investigate the therapeutic potential of specifically targeting MEK in the MAP kinase pathway for thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_provenance.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion evidence source_evidence_literature NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_provenance.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion SIO_000772 18651802 NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_provenance.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion wasDerivedFrom befree-20140225 NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_provenance.
- NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_assertion wasGeneratedBy ECO_0000203 NP209473.RAXPomE2tV3zPV9xfK4E1T0C68rnyVPzZABCuAi8i2UvE130_provenance.